Back to News
Market Impact: 0.18
Xtant Medical Enters Partnership With BioHorizons To Expand Allogeneic Growth Factor Access
Source: Nasdaq
Company FundamentalsHealthcare & Biotech
Xtant Medical Holdings (XTNT) announced an exclusive partnership with BioHorizons, under which BioHorizons will distribute Xtant’s surgical solutions for spinal, orthopaedic, and wound care disorders. The deal is positioned as a commercial distribution expansion, which modestly improves near-term growth prospects but lacks quantified financial impact in the release.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
XTNT0.25
More News
- Musk says Terrafab chip factory could outperform rivals despite challenges
- Will Warner Bros. kill Skydance — or will David Ellison kill Warner Bros?
- Nvidia GPUs are everywhere. Here are the ways companies are accessing them
- How U.S. know-how is fracking Australia into a gas boom, from Texas oilmen to Trump’s energy secretary
- Cerebras Is About as Big as Nvidia's Data Center Business Was Nearly a Decade Ago. The Similarities Mostly End There.
- How Supreme Court justices are leaning in major 401(k) case over private funds and underperformance